Drug Combo May Obviate Chemotherapy in ALL.
Sign Up to like & getrecommendations! Published in 2020 at "Cancer discovery"
DOI: 10.1158/2159-8290.cd-nb2020-99
Abstract: A phase II trial shows that a chemotherapy-free regimen of dasatinib and blinatumomab produces molecular responses in patients with Philadelphia chromosome-positive acute lymphoblastic leukemia. The study found that 60% of patients had molecular responses after… read more here.
Keywords: molecular responses; combo may; obviate chemotherapy; may obviate ... See more keywords